Net profit of Rossari Biotech rose 16.97% to Rs 28.68 crore in the quarter ended June 2022 as against Rs 24.52 crore during the previous quarter ended June 2021. Sales rose 88.10% to Rs 434.71 crore in the quarter ended June 2022 as against Rs 231.11 crore during the previous quarter ended June 2021.
| Particulars | Quarter Ended | ||
| ? | Jun. 2022 | Jun. 2021 | % Var. |
| Sales | 434.71 | 231.11 | 88 |
| OPM % | 13.28 | 16.06 | – |
| PBDT | 54.02 | 39.56 | 37 |
| PBT | 38.70 | 33.24 | 16 |
| NP | 28.68 | 24.52 | 17 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
